Characterization of a cyclooxygenase-2-765G→C promoter polymorphism in human neural cells

NeuroReport

Volumn 16, Issue 6, 2005, Pages 575-579

  Cui, Jian Guo ^a   Salehi Rad, Shabnam ^b   Rogaeva, Ekaterina ^b   Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

9 cis retinoic acid; Alzheimer's disease; Cyclooxygenase 2; Inflammatory response; Interleukin 1 ; Neural cells; Promoter polymorphism

Indexed keywords

ALITRETINOIN; ALITRETINOIN RECEPTOR; CYCLOOXYGENASE 2; CYSTEINE; GLYCINE; INTERLEUKIN 1BETA; POLYPURINE; POLYPYRIMIDINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; BRAIN CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ANALYSIS; GENE CONSTRUCT; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INFLAMMATION; NERVE CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BRAIN DISEASES; CELLS, CULTURED; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEURITIS; NEURONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRANSFECTION;

EID: 17844407880     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200504250-00012     Document Type: Article

References (25)

1. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56:387-437.
2. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2002; 63:901-910.
3. Lukiw WJ, Bazan NG. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 1997; 50:937-945.
4. Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res 1999; 57:295-303.
5. Kitamura Y, Shimohama S, Koike H, Kakimura J, Matsuoka Y, Nomura Y et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun 1999; 254:582-586.
6. Cui JG, Kuroda H, Chandrasekharan NV, Pelaez RP, Simmons DL, Bazan NG et al. Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem Res 2004; 29:1731-1737.
7. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997; 237:28-32.
8. Bazan NG, Lukiw WJ. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 2002; 277:30359-30367.
9. Riazanskaia N, Lukiw WJ, Grigorenko A, Korovaitseva G, Dvoryanchikov G, Moliaka Y et al. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Mol Psychiatry 2002; 7:891-898.
10. Fritsche E, Baek SJ, King LM, Zeldin DC, Eling TE, Bell DA. Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther 2001; 299:468-476.
11. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002; 22:1631-1636.
12. Konheim YL, Wolford JK. Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Hum Genet 2003; 113:377-381.
13. Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 2004; 114:248-253.
14. Koh WP, Yuan JM, van den Berg D, Lee HP, Yu MC. Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br J Cancer 2004; 90:1760-1764.
15. Lukiw WJ, Bazan NG. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. Neurosci Res 1998; 53:583-592.
16. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994; 302:723-727.
17. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004; 328:1-16.
18. Luria A, Furlow JD. Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos. Proc Natl Acad Sci USA 2004; 101:8987-8992.
19. Tsukamoto H, Hishinuma T, Tayama R, Narahara K, Suzuki N, Tomioka Y et al. The induction of prostaglandin E synthase and upregulation of cyclooxygenase-2 by 9-cis retinoic acid. Prostaglandins Other Lipid Mediat 2004; 74:61-74.
20. Bazan NG, Fletcher BS, Herschman HR, Mukherjee PK. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci USA 1994; 91:5252-5256.
21. Gidlof AC, Romert A, Olsson A, Torma H, Eriksson U, Sirsjo A. Increased retinoid signaling in vascular smooth muscle cells by proinflammatory cytokines. Biochem Biophys Res Commun 2001; 286:336-342.
22. Rustighi A, Tessari MA, Vascotto F, Sgarra R, Giancotti V, Manfioletti G. A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genes. Biochemistry 2002; 41:1229-1240.
23. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-238.
24. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928-933.
25. Emahazion T, Feuk L, Jobs M, Sawyer SL, Fredman D, St Clair D et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 2001; 17:407-413.